Model
Edge
Protara Therapeutics Inc.
TARA
Filing Type
S-3
Filing Date
5/13/2026
Updated
5/13/26, 5:17 PM
Filing
S-3
Earnings Release
Exhibits
S-3
Registration Statement for Securities Offered under a Shelf Registration
EX-1.2
SALES AGREEMENT, DATED AS OF MAY 13, 2026, BY AND BETWEEN PROTARA THERAPEUTICS, INC. AND TD SECURITIES (USA), LLC
EX-5.1
OPINION OF KIRKLAND & ELLIS LLP
EX-23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
CALCULATION OF FILING FEE TABLE
GRAPHIC
Graphic
GRAPHIC
Graphic